NCT06659393 - Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Pediatric Chronic Heart Failure

Trial Locations (28)

474 8710

RECRUITING

Novartis Investigative Site, Ōbu

470 1192

RECRUITING

Novartis Investigative Site, Toyoake

812-8582

RECRUITING

Novartis Investigative Site, Fukuoka

830-0011

RECRUITING

Novartis Investigative Site, Kurume

830-8543

RECRUITING

Novartis Investigative Site, Kurume

060 8648

RECRUITING

Novartis Investigative Site, Sapporo

305-8576

RECRUITING

Novartis Investigative Site, Tsukuba

216-8511

RECRUITING

Novartis Investigative Site, Kawasaki

236-0004

RECRUITING

Novartis Investigative Site, Yokohama

514-8507

RECRUITING

Novartis Investigative Site, Tsu

852-8501

RECRUITING

Novartis Investigative Site, Nagasaki

856-8562

RECRUITING

Novartis Investigative Site, Ōmura

700-8558

RECRUITING

Novartis Investigative Site, Okayama

350-1298

RECRUITING

Novartis Investigative Site, Hidaka

330 8777

RECRUITING

Novartis Investigative Site, Saitama

430-8558

RECRUITING

Novartis Investigative Site, Hamamatsu

113 8655

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8431

RECRUITING

Novartis Investigative Site, Bunkyo Ku

113-8603

RECRUITING

Novartis Investigative Site, Bunkyo-ku

183-0003

RECRUITING

Novartis Investigative Site, Fuchū

183-8561

RECRUITING

Novartis Investigative Site, Fuchū

143 8541

RECRUITING

Novartis Investigative Site, Ōta-ku

157-8535

RECRUITING

Novartis Investigative Site, Setagaya-ku

142-8666

RECRUITING

Novartis Investigative Site, Shinagawa-ku

162 8666

RECRUITING

Novartis Investigative Site, Shinjuku Ku

930-0194

RECRUITING

Novartis Investigative Site, Toyama

010-8543

RECRUITING

Novartis Investigative Site, Akita

862-8505

RECRUITING

Novartis Investigative Site, Kumamoto